NL-OMON29611尚未招募不适用
Immunogenicity of HPV-vaccination in a two-dose schedule
ational Institute for Public Health and The Environment, Bilthoven, the Netherlands0 个研究点目标入组 418 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 418
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation
- •in this study:
研究者
相似试验
招募中
不适用
Immunogenicity of HPV-vaccination in a reduced-dose scheduleHPV10047438cervical cancerNL-OMON53042RIVM1,305
Unknown
4 期
KEN SHE StudyCancerPACTR202002647375231niversity of Wshington2,275
进行中（未招募）
不适用
Immune response after Human Papillomavirus vaccination in patients with auto-immune disease - HPV studyEUCTR2008-008169-36-NLniversity Medical Center Utrecht
已完成
4 期
Immune response after Human Papillomavirus vaccination in patients with automimmune diseaseJDMSLE100038161003859410046828Juvenile Idiopathic ArthritisNL-OMON40068niversitair Medisch Centrum Utrecht140
已完成
不适用
Immunogenicity and duration of immunity in immunosuppressed children vaccinated with Human papillomavirus vaccineACTRN12608000260325The Children's Hospital at Westmead59